FDA NDC Directory · JSON-LD · Markdown

DALFAMPRIDINE

NDC 42571-275 · HUMAN PRESCRIPTION DRUG · TABLET, EXTENDED RELEASE

Labeler / ManufacturerMicro Labs Limited
Marketing categoryAbbreviated NDA (generic) · App ANDA210158
Dosage form / routeTABLET, EXTENDED RELEASE · ORAL
Active ingredientsDALFAMPRIDINE (10 mg/1)
Marketing started20190321
Package count3

External sources

Source: openFDA. Public-domain (CC0).